hydroxychloroquine has been researched along with Papillomavirus Infections in 1 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Papillomavirus Infections: Neoplasms of the skin and mucous membranes caused by papillomaviruses. They are usually benign but some have a high risk for malignant progression.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In conclusion, prednisolone and TLR antagonist (hydroxychloroquine) may down-regulate protein levels of TLR7 and TLR9 in lupus patients, thereby decreasing the innate immune response against HPV infection." | 3.78 | Antagonist-mediated down-regulation of Toll-like receptors increases the prevalence of human papillomavirus infection in systemic lupus erythematosus. ( Chan, PK; Cheung, JL; Cheung, TH; Ho, SC; Li, EK; So, K; Szeto, CC; Tam, LS; Wong, CK; Wong, MC; Yeung, AC; Yim, SF; Yu, MM; Yu, SL, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, SL | 1 |
| Chan, PK | 1 |
| Wong, CK | 1 |
| Szeto, CC | 1 |
| Ho, SC | 1 |
| So, K | 1 |
| Yu, MM | 1 |
| Yim, SF | 1 |
| Cheung, TH | 1 |
| Wong, MC | 1 |
| Cheung, JL | 1 |
| Yeung, AC | 1 |
| Li, EK | 1 |
| Tam, LS | 1 |
1 other study available for hydroxychloroquine and Papillomavirus Infections
| Article | Year |
|---|---|
Antagonist-mediated down-regulation of Toll-like receptors increases the prevalence of human papillomavirus infection in systemic lupus erythematosus.
Topics: Cross-Sectional Studies; Down-Regulation; Female; HeLa Cells; Humans; Hydroxychloroquine; Lupus Eryt | 2012 |